This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Trualt Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2025 ,inter alia, to consider and approve the unaudited (Standalone ....
TRUALT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.3 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Trualt Bioenergy has informed BSE that its Board of Directors will meet on Sunday, October 19, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The trading window for designated persons has already been closed from October 1, 2025 and will remain closed until 48 hours after the results are declared. This is a standard regulatory filing under SEBI LODR Regulation 29(1) ahead of the results announcement.
No direct impact on shareholders. Investors should watch for the actual Q1 FY26 results on or after October 19, 2025, which will reveal the company's quarterly performance and set the tone for the stock.
| Q2 FY26 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹114.9 Cr | — | — |
| Profit after tax | −₹37.94 Cr | — | — |
From the company's XBRL filing, not from the text above. Operating profit and EBITDA margin are not shown for banks and lenders, whose other income is their business. No year-ago figures on this basis yet, so no comparison.